Chem-/Biotech

At high speed to new pharmaceuticals

DyNAbind GmbH

DyNAbind GmbH offers innovative products and services for pharmaceutical research based on the use of its patented dynamic DNA-encoded library technology. This allows DyNAbind to simultaneously test hundreds of millions of substances on a target protein. With the help of the in-house developed „Binding Profiler“ system, the validation and profiling of hit substances takes place immediately afterwards. Compared to competitors, DyNAbind delivers high quality, well-developable starting points for optimization to the pharmaceutical and is 10 times faster than conventional techniques.

TGFS has been a shareholder in the company together with High-Tech Gründerfonds since 2020.